specimen or on a biopsy taken from a metastasis. All patients had multiple skeletal-and/or lymph node-and/or soft tissueand/or visceral metastases. All patients had measurable signs of progressive growth of their malignancy.
Pulmonary metastases were not considered to be reliable for assessing progress of metastases as in a previous study it became evident that these metastases have a tendency towards unpredictable spontaneous fluctuation and regression (WerfMessing and Gilse, 1971 ).
Painful or "dangerous" lesions, for instance metastases with risk of fracture, cord compression, inferior vena cava obstruction, etc, were treated by radiotherapy.
Eighteen patients (4 females and 14 males) selected according to the above mentioned criteria, received multiple drug therapy. The majority of patients had previously been treated unsuccessfully with megestrol acetate, 60 mg daily. The average age of the patients was 61 years.
Because of serious complications, progressive metastases or death in spite of chemotherapy, only one course was given in 2 cases. For the same reasons treatment was not repeated after two courses in 5 cases; 11 patients received three or more courses of multiple drug therapy.
In no case could objective response to chemotherapy be detected. Slight subjective improvement was observed in one patient. In another case it was doubtful whether subjective improvement was real or just the improvement after recovery from side-effects of chemotherapy.
As a rule the complications of this treatment were not severe: severe nausea (6 cases), severe thrombopenia (1 case), loss of hair (2 cases, of which one in combination with severe nausea), cardiac failure (1 case), ulceration of buccal mucosa (3 cases), sepsis (1 case), candida infection (1 case).
Though 
